Wells Fargo
NEPH icon

Wells Fargo’s Nephros NEPH Stock Holding History

Wells Fargo’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-73
Closed -$160 – 7273
2024
Q1 		$160 Buy
73
+1
+1% +$3 ﹤0.01% 6548
2023
Q4 		$249 Buy
72
+4
+6% +$9 ﹤0.01% 6552
2023
Q3 		$101 Buy
68
+2
+3% +$3 ﹤0.01% 6766
2023
Q2 		$102 Buy
66
+3
+5% +$4 ﹤0.01% 6856
2023
Q1 		$67 Buy
63
+1
+2% +$1 ﹤0.01% 7029
2022
Q4 		$72 Buy
62
+2
+3% +$2 ﹤0.01% 6888
2022
Q3 		$0 Buy
60
+3
+5% +$4 ﹤0.01% 7126
2022
Q2 		$0 Buy
57
+5
+10% +$13 ﹤0.01% 7256
2022
Q1 		$0 Buy
52
+1
+2% +$5 ﹤0.01% 7560
2021
Q4 		$0 Hold
51
– – ﹤0.01% 7613
2021
Q3 		$0 Sell
51
-5
-9% -$43 ﹤0.01% 7328
2021
Q2 		$1K Hold
56
– – ﹤0.01% 6701
2021
Q1 		$0 Hold
56
– – ﹤0.01% 7210
2020
Q4 		$0 Buy
56
+8
+17% +$54 ﹤0.01% 6828
2020
Q3 		$0 Buy
48
+19
+66% +$139 ﹤0.01% 6695
2020
Q2 		$0 Hold
29
– – ﹤0.01% 6636
2020
Q1 		$0 Buy
+29
New +$246 ﹤0.01% 6591

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wells Fargo's NEPH Position: Q2 2024 in Review

Wells Fargo sold out of Nephros (NEPH) in Q2 2024, closing a stake of 73 shares — an estimated $160 sold.

Wells Fargo first reported a position in NEPH in Q1 2020 and held it in 17 quarters. The position peaked at $1K in Q2 2021. 19 funds tracked by Wall St. Rank hold NEPH as of Q2 2024.

  • Wells Fargo reported no remaining Nephros position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 73 Nephros shares in Q2 2024, an estimated $160.
  • Wells Fargo first reported a position in Nephros in Q1 2020 and held it in 17 quarters.
  • Wells Fargo's Nephros position peaked at $1K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Nephros as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.